Variant report
Variant | nsv1037228 |
---|---|
Chromosome Location | chr10:56377898-56405762 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-MTRNR2L5-4 | chr10:56378894-56379084 | NONHSAT013457 |
2 | lnc-MTRNR2L5-4 | chr10:56378894-56379084 | ENSG00000234173.1 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs2384516 | chr10:56377898-56377899 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs536934178 | chr10:56377934-56377935 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs7098661 | chr10:56377945-56377946 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs7099733 | chr10:56377973-56377974 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs539192113 | chr10:56377996-56377997 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs150540841 | chr10:56378007-56378008 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs117401733 | chr10:56378014-56378015 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs370525423 | chr10:56378018-56378019 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs543815849 | chr10:56378042-56378043 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs139502505 | chr10:56378145-56378146 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs7099039 | chr10:56378165-56378166 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs191524450 | chr10:56378182-56378183 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs201735823 | chr10:56378241-56378242 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs560330642 | chr10:56378242-56378243 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs532222320 | chr10:56378260-56378261 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs552319933 | chr10:56378311-56378312 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs367858635 | chr10:56378381-56378382 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs564969166 | chr10:56378442-56378443 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs530984966 | chr10:56378456-56378457 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs7099464 | chr10:56378458-56378459 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs377103211 | chr10:56378524-56378525 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs532145528 | chr10:56378532-56378533 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs149614659 | chr10:56378557-56378558 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs373036753 | chr10:56378620-56378621 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs536641084 | chr10:56378676-56378677 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs562316194 | chr10:56378746-56378747 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs530449076 | chr10:56378816-56378817 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs144315334 | chr10:56378831-56378832 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs567128968 | chr10:56378863-56378864 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs201958521 | chr10:56378864-56378865 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs529844575 | chr10:56378873-56378874 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs78567409 | chr10:56378888-56378889 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs79945966 | chr10:56378908-56378909 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
34 | rs558687796 | chr10:56378910-56378911 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
35 | rs398075173 | chr10:56378914-56378915 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
36 | rs201190525 | chr10:56378916-56378917 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
37 | rs568653162 | chr10:56378933-56378934 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
38 | rs184058614 | chr10:56379016-56379017 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
39 | rs537546344 | chr10:56379069-56379070 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
40 | rs201728695 | chr10:56379077-56379078 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
41 | rs554171988 | chr10:56379085-56379086 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs566472036 | chr10:56379089-56379090 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs75613671 | chr10:56379103-56379104 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs566257695 | chr10:56379136-56379137 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs147704519 | chr10:56379137-56379138 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs540191438 | chr10:56379144-56379145 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs187281995 | chr10:56379193-56379194 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs141060178 | chr10:56379195-56379196 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs144920646 | chr10:56379213-56379214 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs207470944 | chr10:56379251-56379252 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Pancreatic endocrine tumor | 17639061 | CNVD |
Gastric cancer | 17908304 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Melanoma | 18172304 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 20724749 | CNVD |
Autism | 22495311 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 18632612 | CNVD |
Autism | 18414403 | CNVD |
Cockayne syndrome | 18421352 | CNVD |
Glioblastoma | 16823260 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Neuroblastoma | 17533364 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Glioma | 21971842 | CNVD |
Cancer | 21637783 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Obesity | 21956041 | CNVD |
Developmental delay | 21948486 | CNVD |
Intellectual disability | 21948486 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Autism | 20841430 | CNVD |
Mental retardation | 17124404 | CNVD |
Epilepsy | 20923578 | CNVD |
Prostate cancer | 16573809 | CNVD |
Schizophrenia | 19329560 | CNVD |
Heart failure | 18772530 | CNVD |
Heart failure | 18854381 | CNVD |
Hyperglycemia | 19060297 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Usher syndrome | 20538994 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Autism | 20858243 | CNVD |
Breast cancer | 22522925 | CNVD |
Usher type I cohort | 17277737 | CNVD |
Usher type I cohort | 21436283 | CNVD |
Leukemia | 21357790 | CNVD |
Medulloblastoma | 22832581 | CNVD |
Melanoma | 17363583 | CNVD |
Cancer | 20164919 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr10:56373800-56381200 | Weak transcription | HUVEC | blood vessel |
2 | chr10:56374000-56381200 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
3 | chr10:56381200-56381400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
4 | chr10:56381200-56381400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
5 | chr10:56381200-56382200 | Flanking Active TSS | HUVEC | blood vessel |
6 | chr10:56381400-56381800 | Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
7 | chr10:56381400-56381800 | Active TSS | Primary hematopoietic stem cells | blood |
8 | chr10:56381400-56381800 | Active TSS | Primary hematopoietic stem cells short term culture | blood |
9 | chr10:56381400-56381800 | Flanking Active TSS | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
10 | chr10:56381400-56382000 | Flanking Active TSS | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
11 | chr10:56381600-56382200 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
12 | chr10:56381800-56382000 | Flanking Active TSS | Primary hematopoietic stem cells | blood |
13 | chr10:56381800-56382000 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
14 | chr10:56381800-56382200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
15 | chr10:56382000-56382200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
16 | chr10:56382200-56383000 | Enhancers | HUVEC | blood vessel |